financetom
Business
financetom
/
Business
/
Avery Dennison Insider Sold Shares Worth $657,517, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Avery Dennison Insider Sold Shares Worth $657,517, According to a Recent SEC Filing
May 13, 2024 11:32 AM

02:05 PM EDT, 05/13/2024 (MT Newswires) -- Gregory Lovins, Senior Vice President and CFO, on May 10, 2024, sold 2,894 shares in Avery Dennison (AVY) for $657,517. Following the Form 4 filing with the SEC, Lovins has control over a total of 69,623 shares of the company, with 67,457 shares held directly and 2,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/8818/000112760224015065/xslF345X03/form4.xml

Price: 224.21, Change: -1.40, Percent Change: -0.62

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thousands of YouTube outages reported in Russia
Thousands of YouTube outages reported in Russia
Aug 8, 2024
MOSCOW, Aug 8 (Reuters) - Russian internet monitoring services reported thousands of glitches in the availability of video hosting site YouTube on Thursday, amid escalating criticism of the platform by the Russian authorities. Russian internet monitoring service Sboi.rf said that there had been thousands of glitches reported about YouTube in Russia. Users said they could only access YouTube via virtual...
Sweden's EQT to acquire majority stake in Switzerland's Acronis
Sweden's EQT to acquire majority stake in Switzerland's Acronis
Aug 8, 2024
Aug 7 (Reuters) - Swedish financial investor EQT said on Wednesday it will acquire a majority stake in Swiss cybersecurity and data protection company Acronis. The company said in a statement it will buy the stake through a private equity fund, by buying shares from other investors such as CVC, Springcoast Capital Partners and BlackRock ( BLK ). They will...
Vertex Pharmaceuticals Signs Reimbursement Deal in England for Transfusion-Dependent Beta Thalassemia Treatment
Vertex Pharmaceuticals Signs Reimbursement Deal in England for Transfusion-Dependent Beta Thalassemia Treatment
Aug 8, 2024
05:01 AM EDT, 08/08/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said late Wednesday it signed a reimbursement agreement with NHS England to give eligible patients access to the company's Casgevy therapy for the treatment of transfusion-dependent beta thalassemia. The company said the deal comes as the National Institute for Health and Care Excellence, or NICE, issued a positive...
Update: Corpay Q2 Adjusted Earnings, Revenue Rise But Q3 Outlook Lags; Shares Slump Premarket
Update: Corpay Q2 Adjusted Earnings, Revenue Rise But Q3 Outlook Lags; Shares Slump Premarket
Aug 8, 2024
05:05 AM EDT, 08/08/2024 (MT Newswires) -- (Updates with the stock move in the headline and the sixth paragraph.) Corpay ( CPAY ) reported Q2 adjusted earnings late Wednesday of $4.55 per diluted share, up from $4.19 a year earlier. Analysts surveyed by Capital IQ expected $4.51. Revenue in the quarter ended June 30 rose to $975.7 million from $948.2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved